Mackay Shields LLC’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-77,049
| Closed | -$966K | – | 1227 |
|
|
2021
Q1 | $966K | Sell |
77,049
-60,733
| -44% | -$761K | 0.01% | 1007 |
|
|
2020
Q4 | $2.15M | Buy |
137,782
+8,900
| +7% | +$139K | 0.01% | 827 |
|
|
2020
Q3 | $1.22M | Sell |
128,882
-19,700
| -13% | -$186K | 0.01% | 964 |
|
|
2020
Q2 | $1.33M | Buy |
148,582
+6,900
| +5% | +$61.9K | 0.01% | 925 |
|
|
2020
Q1 | $902K | Buy |
141,682
+26,400
| +23% | +$168K | 0.01% | 982 |
|
|
2019
Q4 | $965K | Buy |
115,282
+9,100
| +9% | +$76.2K | 0.01% | 1074 |
|
|
2019
Q3 | $961K | Sell |
106,182
-7,200
| -6% | -$65.2K | 0.01% | 1120 |
|
|
2019
Q2 | $1.22M | Buy |
113,382
+72,733
| +179% | +$783K | 0.01% | 1073 |
|
|
2019
Q1 | $388K | Buy |
40,649
+1,300
| +3% | +$12.4K | ﹤0.01% | 1231 |
|
|
2018
Q4 | $452K | Sell |
39,349
-4,151
| -10% | -$47.7K | ﹤0.01% | 1171 |
|
|
2018
Q3 | $737K | Buy |
43,500
+9,800
| +29% | +$166K | 0.01% | 936 |
|
|
2018
Q2 | $478K | Hold |
33,700
| – | – | ﹤0.01% | 1105 |
|
|
2018
Q1 | $640K | Buy |
+33,700
| New | +$640K | ﹤0.01% | 1076 |
|